電子ドラッグデリバリーシステムの世界市場予測:電子ウェアラブル注入ポンプ、自動注射器、注射ペン、電子吸入器

LINEで送る

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Analysis
2.5 Assumptions for the Study
3 Executive Summary (Page No. – 25)
4 Premium Insights (Page No. – 28)
4.1 Electronic Drug Delivery Systems: Market Overview
4.2 North America: Market, By Type, 2018
4.3 Geographical Snapshot of the Market
5 Market Overview (Page No. – 31)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Target Diseases
5.2.1.2 Favorable Reimbursement Scenario in Major Markets
5.2.1.3 Advancements in Technologies and Designs
5.2.2 Restraints
5.2.2.1 Preference for Alternative Drug Delivery Modes and the Possibility of Errors
5.2.3 Opportunities
5.2.3.1 Increasing Demand for Biologics and Mabs
5.2.3.2 Growth Opportunities in Emerging Markets
5.2.4 Challenges
5.2.4.1 Unfavorable Reimbursement Structure in Developing Countries
6 Market, By Type (Page No. – 36)
6.1 Introduction
6.1.1 Electronic Wearable Infusion Pumps
6.1.1.1 Electronic Wearable Infusion Pumps Dominate the Market
6.1.2 Electronic Autoinjectors
6.1.2.1 Electronic Autoinjectors are Likely to Register Negative Growth During the Forecast Period Due to the Continuous Influx of Generic Versions of Conventional Autoinjectors in the Market
6.1.3 Electronic Injection Pens
6.1.3.1 Growing Focus of Pharmaceutical Companies on Developing Electronic/Connected Injection Pens Will Drive Market Growth
6.1.4 Electronic Inhalers
6.1.4.1 Electronic Inhalers are Developed to Improve Medication Adherence in Asthma & COPD Management
7 Market, By Indication (Page No. – 48)
7.1 Introduction
7.2 Diabetes
7.2.1 Diabetes Accounted for the Largest Segment of the Market
7.3 Multiple Sclerosis
7.3.1 Launch of Generic Versions of Conventional Injectables Will Stifle Market Growth
7.4 Cardiovascular Disease
7.4.1 Development of Innovative Electronic Drug Delivery Systems for Cvd Treatment Will Drive Market Growth
7.5 Asthma & COPD
7.5.1 Development of Smart Inhalers and Digital Sensors is Likely to Improve Medication Adherence in Asthma & COPD Patients
7.6 Other Indications
8 Market, By Region (Page No. – 61)
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 The US has A Favorable Reimbursement Scenario for Electronic Drug Delivery Devices, Which is A Key Factor Driving the Market for Electronic Drug Delivery Systems
8.2.2 Canada
8.2.2.1 Growing Presence of Device Manufacturers in the Country is Expected to Propel Market Growth
8.3 Europe
8.3.1 Germany
8.3.1.1 Germany is the Largest Market for Electronic Drug Delivery Systems in Europe
8.3.2 UK
8.3.2.1 High Burden of Target Diseases to Support Market Growth
8.3.3 France
8.3.3.1 High Prevalence of Diabetes in the Country to Propel Market Growth
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Large Geriatric Population and the High Prevalence of Cvd to Support Market Growth
8.4.2 China
8.4.2.1 Growing Focus of Major Players on Biologics Development to Drive Market Growth
8.4.3 India
8.4.3.1 Lack of Reimbursement and Guidelines on Electronic Drug Delivery Systems Could Limit Market Growth
8.4.4 RoAPAC
8.5 Rest of the World
8.5.1 Latin America
8.5.1.1 High Incidence of Chronic Diseases to Drive the Demand for Electronic Drug Delivery Systems
8.5.2 Middle East & Africa
8.5.2.1 Favorable Reforms in South Africa to Support Market Growth
9 Competitive Landscape (Page No. – 88)
9.1 Overview
9.2 Market Share Analysis
9.3 Key Player Analysis
9.3.1 Merck Group
9.3.2 Medtronic PLC
9.4 Competitive Scenario
9.4.1 Product Launches
9.4.2 Expansions
9.4.3 Agreements & Collaborations
9.5 Competitive Leadership Mapping (2018)
9.5.1 Visionary Leaders
9.5.2 Innovators
9.5.3 Dynamic Differentiators
9.5.4 Emerging Companies
10 Company Profiles (Page No. – 94)
10.1 Merck Group
10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Recent Developments
10.2 Medtronic PLC
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Recent Developments
10.3 United Therapeutics Corporation
10.3.1 Business Overview
10.3.2 Products Offered
10.3.3 Recent Developments
10.4 Insulet Corporation
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Recent Developments
10.5 Bayer AG
10.5.1 Business Overview
10.5.2 Products Offered
10.5.3 Recent Developments
10.6 Novo Nordisk
10.6.1 Business Overview
10.6.2 Products Offered
10.6.3 Recent Developments
10.7 Companion Medical
10.7.1 Business Overview
10.7.2 Products Offered
10.7.3 Recent Developments
10.8 Tandem Diabetes Care, Inc.
10.8.1 Business Overview
10.8.2 Products Offered
10.8.3 Recent Developments
10.9 F.Hoffmann-La Roche, Ltd.
10.9.1 Business Overview
10.9.2 Products Offered
10.9.3 Recent Developments
10.10 Amgen, Inc.
10.10.1 Business Overview
10.10.2 Products Offered
10.10.3 Recent Developments
10.11 Astrazeneca PLC
10.11.1 Business Overview
10.11.2 Products Offered
10.11.3 Recent Developments
10.12 Findair SP. Z O. O.
10.12.1 Business Overview
10.12.2 Products Offered
10.12.3 Recent Developments
10.13 Vicentra B.V.
10.13.1 Business Overview
10.13.2 Products Offered
10.13.3 Recent Developments
10.14 Canè SPA
10.14.1 Business Overview
10.14.2 Products Offered
10.15 Debiotech S.A.
10.15.1 Business Overview
10.15.2 Products Offered
11 Appendix (Page No. – 119)
11.1 Discussion Guide
11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.3 Related Reports
11.4 Author Details




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様